Matching articles for "Journavx"
Issue 1743 · December 8, 2025 Free
Prenatal Acetaminophen Use and Autism

Acetaminophen has been considered the drug of choice for treatment of fever and pain during pregnancy for decades, but a recent announcement by the US Department of Health and Human Services (HHS) has prompted…

Med Lett Drugs Ther. 2025 Dec 8; 67(1743):193-5 doi:10.58347/tml.2025.1743a
Acetaminophen has been considered the drug of choice for treatment of fever and pain during pregnancy for decades, but a recent announcement by the US Department of Health and Human Services (HHS) has prompted discussion about its effects on fetal neurodevelopment and the risk of autism.
Issue 1723 · March 3, 2025 Free
Suzetrigine (Journavx) — A Sodium Channel Blocker for Acute Pain

The FDA has approved suzetrigine ( Journavx – Vertex), a selective sodium channel blocker, for oral treatment of moderate to severe acute pain in adults. Suzetrigine is the first sodium channel blocker to be…

Med Lett Drugs Ther. 2025 Mar 3; 67(1723):33-5 doi:10.58347/tml.2025.1723a
The FDA has approved suzetrigine ( Journavx – Vertex), a selective sodium channel blocker, for oral treatment of moderate to severe acute pain in adults. Suzetrigine is the first sodium channel blocker to be approved in the US for this indication and the first oral nonopioid drug to be approved for treatment of pain in over 25 years.